As technology advances, AI-powered tools will increasingly reduce the administrative burdens on healthcare providers.| MedCity News
Sponsored Post, | MedCity News
Executives from Imagine360, Verily, BrightInsight, Lantern, and Rhapsody shared their approaches to reducing healthcare costs and facilitating digital transformation.| MedCity News
FDA granted marketing authorization for the First To Know Syphilis Test, the first at-home, over-the-counter test to detect syphilis antibodies in human blood.| U.S. Food and Drug Administration
NOWDiagnostics’ First To Know has FDA De Novo marketing authorization as a new test for syphilis. The at-home product needs only a single drop of blood to test for this sexually transmitted infection.| MedCity News
Healthcare technology news, health IT companies| MedCity News